Document is current
Any future updates will be listed below
-
Authors
Harrison, Judith R. https://orcid.org/0000-0002-5775-2524
Colloby, Sean J.
O’Brien, John T.
Taylor, John-Paul
-
Funding
Funding for this research was provided by:
Medical Research Council (G9817682)
- License Information
-
More Information
Article History
Received: 16 June 2025
Revised: 11 August 2025
Accepted: 12 August 2025
First Online: 29 September 2025
Declarations
:
: Dr Harrison works as a clinical advisor for Akrivia Health and the Medicines and Healthcare products Regulatory Authority (MHRA), on matters unrelated to this work. Dr Colloby reports no disclosures. Professor O’Brien has acted as a consultant for TauRx, Novo Nordisk, Biogen, Roche, Lilly, GE Healthcare and Okwin and received grants or academic in kind support from Avid/Lilly, Merck, UCB and Alliance Medical. Professor Taylor has received honoraria for talks from GE Healthcare and consulted for CervoMed and Eisai.
: The study was approved by the Newcastle, North Tyneside and Northumberland local research ethics committee and the UK Department of Health’s Administration of Radioactive Substances Advisory Committee (ARSAC).
: All participants and/or nearest relative (for patients who lacked capacity) gave informed written consent.
